ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

SWTX SpringWorks Therapeutics Inc

40,67
1,76 (4,52%)
Após o horário de negociação
Última atualização: 18:38:16
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
SpringWorks Therapeutics Inc SWTX NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
1,76 4,52% 40,67 18:38:16
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
39,22 38,80 41,01 40,67 38,91
mais cotações »

Notícias Recentes

Data Hora Fonte Título
05/06/202408:00GLOBESpringWorks Therapeutics to Participate in the Goldman Sachs..
23/05/202418:13GLOBESpringWorks Therapeutics Announces Data to be Presented at..
08/05/202408:00GLOBESpringWorks Therapeutics to Participate in the BofA..
02/05/202407:30GLOBESpringWorks Therapeutics Reports First Quarter 2024..
24/04/202414:31GLOBESpringWorks Therapeutics Announces Abstracts Accepted for..
18/04/202408:00GLOBESpringWorks Therapeutics to Report First Quarter 2024..
04/03/202408:30GLOBESpringWorks Therapeutics Initiates Rolling Submission of New..
29/02/202410:30GLOBESpringWorks Therapeutics Announces European Medicines Agency..
27/02/202408:30GLOBESpringWorks Therapeutics Reports Fourth Quarter and Full..
22/02/202409:00GLOBESpringWorks Therapeutics to Present at Upcoming Investor..
31/01/202409:00GLOBESpringWorks Therapeutics to Participate in the Guggenheim..
08/01/202408:30GLOBESpringWorks Therapeutics Highlights 2023 Accomplishments and..
21/12/202309:00GLOBESpringWorks Therapeutics to Present at the 42nd Annual J.P...
08/12/202318:05GLOBESpringWorks Therapeutics Announces Closing of Upsized Public..
05/12/202302:32GLOBESpringWorks Therapeutics Announces Pricing of Upsized Public..
04/12/202318:13GLOBESpringWorks Therapeutics Announces Proposed Public Offering..
29/11/202309:00GLOBESpringWorks Therapeutics to Participate in the 6th Annual..
28/11/202309:53DJNSpringWorks Shares Rise on FDA Approval for Tumor Treatment
27/11/202320:46DJNSpringWorks Gets FDA Approval for Desmoid Tumor Treatment
27/11/202320:04GLOBESpringWorks Therapeutics Announces FDA Approval of OGSIVEO™..
16/11/202308:30GLOBESpringWorks Therapeutics Announces Positive Topline Results..
02/11/202307:30GLOBESpringWorks Therapeutics Reports Third Quarter 2023..
01/11/202307:30GLOBESpringWorks Therapeutics Announces Presentation of..
11/09/202307:30GLOBESpringWorks Therapeutics Appoints Dr. Tai-An Lin as Chief..
02/08/202307:30GLOBESpringWorks Therapeutics Reports Second Quarter 2023..
07/06/202308:00GLOBESpringWorks Therapeutics to Participate in the Goldman Sachs..